FDA
-
-
-
-
-
-
-
Vericel reports preliminary 2025 revenue of $276 million
-
-
-
-
-
-
-
Vericel (VCEL) Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
-
-
-
-
-
-
-
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
-
-
-
-
-
-
-
Vericel (VCEL) Reports Prelim Q4 Results
-
-
-
-
-
-
-
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
-
-
-
-
-
-
-
MediWound (MDWD) Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
-
-
-
-
-
-
-
Vericel Reports Third Quarter 2022 Financial Results
-
322,088 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

